Master Your Journey: A Detailed Guide on How to Use Wegovy Shot for Weight Management

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that reduces hunger signals in the brain and slows stomach emptying, helping patients achieve meaningful weight loss. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies at $189/mo month-to-month, or from $149/mo on the 6-month plan across all commitment tiers—your dose may need to go up, but your price won't. Understanding how to use this medication correctly maximizes safety and effectiveness.

How Semaglutide Injections Work in Your Body

Semaglutide mimics a natural hormone your gut releases after eating. When this hormone binds to GLP-1 receptors in your brain, it activates centers that regulate appetite and blood sugar. The medication also delays gastric emptying, meaning food stays in your stomach longer, which extends feelings of fullness between meals. Clinical trials show patients on semaglutide reduce calorie intake by approximately 500–800 calories daily without conscious restriction.

The drug works on multiple pathways simultaneously. It increases insulin secretion when blood glucose rises, suppresses glucagon release when it's too high, and reinforces satiety signals throughout your digestive tract. These coordinated effects explain why patients often report less food preoccupation and fewer cravings within the first few weeks. The mechanism is fundamentally different from stimulant-based weight loss drugs, making semaglutide suitable for long-term use.

Preparing and Administering Your Semaglutide Injection

Your semaglutide pen arrives with detailed instructions and is pre-filled for convenience. Before each injection, inspect the solution for cloudiness or particles—it should be clear and colorless. Store your pen in the refrigerator between 36°F and 46°F until you begin using it; once opened, most pens remain stable at room temperature for 28 days. Allow the pen to sit on a clean surface for 10–15 minutes before injecting if you've just removed it from the fridge.

Inject subcutaneously into the abdomen, thigh, or upper arm, rotating injection sites weekly to minimize irritation and lipodystrophy. Pinch skin with one hand, insert the needle at a 45–90 degree angle with the other, and hold for several seconds after releasing the plunger. Most patients report mild discomfort similar to a flu shot. Common injection-site reactions—redness, swelling, itching—typically resolve within hours to days and decrease with consistent rotation technique.

Expected Timeline and Results from Semaglutide

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Wegovy or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Most weight loss occurs in the first 16 weeks and then stabilizes as your body reaches a new equilibrium. Continue the medication at your effective maintenance dose to sustain results; discontinuing semaglutide often leads to weight regain. Energy levels frequently improve after the initial 4–6 weeks as appetite normalizes and metabolic processes adapt. Many patients report secondary benefits including better sleep quality, reduced joint pain, and improved mood, though these are not primary treatment endpoints.

Managing Side Effects and Optimizing Your Experience

Nausea is the most common side effect, occurring in 20–40% of patients during dose escalation. This typically resolves within 3–7 days as your body adapts; eating smaller, lower-fat meals and staying hydrated minimize discomfort. Other transient effects include mild constipation, diarrhea, or fatigue—all tend to improve with time. Serious adverse events are rare and include pancreatitis (extremely uncommon), gallbladder issues, or allergic reactions. Inform your PlexusDx provider immediately if you experience severe abdominal pain, persistent vomiting, or signs of an allergic response.

Optimize your experience by pairing semaglutide with consistent protein intake—aim for 25–30 grams per meal to preserve lean muscle during weight loss and enhance satiety. Adequate hydration (at least 2.5 liters daily) supports healthy digestion and may reduce nausea. Gentle exercise like walking, swimming, or resistance training amplifies fat loss while maintaining metabolic health. PlexusDx coordinates your injection schedule with your lifestyle; all 50 states are served with no insurance requirement, and HSA/FSA accounts are eligible for reimbursement.

Personalization Through Genetic Testing and Precision Medicine

Not everyone responds to semaglutide identically. Genetic variants in your glucose-dependent insulinotropic polypeptide receptor (GIPR rs1800437), melanocortin-4 receptor (MC4R rs17782313), and fat mass obesity-associated gene (FTO rs9939609) influence how effectively the medication suppresses hunger and accelerates weight loss. PlexusDx maps 14 peptide-pathway systems across 49 unique peptides and delivers 150+ genetic insights through the Precision Peptide Genetic Test. This test identifies your individual predispositions and allows your clinician to optimize your compound formulation, dose escalation rate, and complementary therapies.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How often do I inject semaglutide, and does the schedule change?

Semaglutide is injected once weekly on the same day each week. Your provider may recommend starting at a low dose (0.25 mg) and increasing gradually every 4 weeks to minimize side effects and allow your body to acclimate. PlexusDx coordinates this schedule with your clinical history; your dose may increase over time, but your monthly price stays flat at $189/month across all tiers.

What clinical evidence supports semaglutide for weight loss?

The STEP trials published in the New England Journal of Medicine demonstrated that patients on semaglutide 2.4 mg weekly achieved average weight losses of 12–15% over 68 weeks compared to 2–3% with placebo. A large meta-analysis of GLP-1 receptor agonists confirms sustained weight reduction and improved cardiometabolic markers including blood pressure and lipid levels.

Does PlexusDx require insurance or membership to prescribe semaglutide?

No. PlexusDx serves all 50 states without insurance requirements or membership fees. Compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and are HSA/FSA eligible, offering affordability and flexibility alongside clinical personalization through the optional Precision Peptide Genetic Test.

Are there any contraindications or medical conditions that prevent semaglutide use?

Absolute contraindications include a personal or family history of medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN 2). Caution is advised in patients with diabetic retinopathy, severe kidney or liver disease, or acute pancreatitis. PlexusDx clinicians review your full medical history before prescribing to ensure safety.

Can genetic testing help me understand whether semaglutide will work for me?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Weight Management Peptide Pathway Guide
• Wegovy For Losing Weight
• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.